Cellulitis vs Abscess — Diagnosis & Treatment

Key Points

• Do not treat every red swollen leg as cellulitis; bilateral disease and chronic scaling often indicate a mimic.
• Abscess management is centered on incision and drainage, not antibiotic escalation alone.
• Routine MRSA coverage is unnecessary for uncomplicated nonpurulent cellulitis without specific risk factors.
• Point-of-care ultrasound can identify an occult fluid collection when fluctuance is absent or examination is limited.
• Rapid progression, severe pain, bullae, crepitus, shock, or skin anesthesia should trigger urgent evaluation for necrotizing infection.
• Address predisposing edema, interdigital fungal disease, ulcers, and skin barrier disruption to reduce recurrence.
• Culture pus from selected abscesses, but blood cultures are generally reserved for severe systemic illness or unusual hosts.
• Reassess apparent treatment failure for an undrained collection, resistant organism, incorrect diagnosis, or deeper infection.

Algorithm

1. Determine whether the process is nonpurulent cellulitis, purulent infection, or a noninfectious mimic.
2. Assess vital signs, immune status, anatomic site, rate of progression, and features suggesting necrotizing infection.
3. Use bedside ultrasound when a collection is possible but not clinically obvious.
4. Drain a confirmed abscess and send culture when severity, recurrence, or host factors make the result clinically useful.
5. For uncomplicated nonpurulent cellulitis, choose streptococcal-active therapy; add MRSA coverage only when indicated.
6. Provide elevation, analgesia, wound care, and treatment of portals of entry or chronic edema.
7. Escalate to intravenous therapy, admission, and specialty consultation for severe or complicated disease.
8. Reassess within an appropriate interval and investigate lack of improvement for missed source control or an alternative diagnosis.

Clinical Synopsis & Reasoning

Cellulitis typically causes expanding erythema, warmth, edema, and tenderness with poorly demarcated borders. Nonpurulent disease is most often associated with beta-hemolytic streptococci, and routine attempts to culture intact skin are low yield. Purulence, focal fluctuance, spontaneous drainage, or a discrete tender mass favors abscess. Bedside ultrasound is useful when examination cannot distinguish cellulitis from a drainable collection, particularly in obesity, induration, previous surgery, or lesions that have already partially drained. Search for an entry site such as tinea pedis, fissures, ulcers, trauma, injection sites, or edema-related skin breakdown. Marking the margin can help document progression, but transient extension during the first day of treatment does not by itself prove treatment failure. Fever, tachycardia, hypotension, rapidly progressive pain, pain out of proportion, bullae, ecchymosis, crepitus, skin anesthesia, or systemic toxicity should prompt evaluation for necrotizing soft tissue infection rather than routine cellulitis. Facial and periorbital infection, hand infection, infection over a prosthetic joint, bite wounds, immersion injuries, and infections in profoundly immunocompromised patients require a broader differential and often specialty input. Bilateral lower-leg erythema is less typical for cellulitis and should raise consideration of venous stasis, lipodermatosclerosis, heart failure-related edema, contact dermatitis, or another inflammatory mimic.

Treatment Strategy & Disposition

For mild nonpurulent cellulitis without systemic instability, use an oral agent active against streptococci and methicillin-susceptible Staphylococcus aureus when clinically appropriate, such as cephalexin or an equivalent selected for allergy and local susceptibility patterns. Routine MRSA coverage is not necessary for every case of nonpurulent cellulitis. Add MRSA-active therapy when there is purulent drainage, a concurrent abscess, penetrating trauma, prior MRSA infection or colonization, injection-drug exposure, severe systemic illness, or another locally relevant risk. A fluctuant abscess should undergo incision and drainage with adequate disruption of loculations; obtain a culture when infection is severe, recurrent, unusually located, associated with immunocompromise, or likely to influence antibiotic selection. Five days of antibiotics is often sufficient for improving uncomplicated cellulitis, but extend treatment when response is slow or infection is complicated. Elevation and management of edema improve comfort and may reduce recurrence. Admit patients with hemodynamic instability, concern for deep or necrotizing infection, rapidly progressive disease, inability to take or absorb oral therapy, severe immunocompromise, failure of appropriate outpatient therapy, or unreliable follow-up. Suspected necrotizing infection requires immediate surgical consultation, broad intravenous antibiotics, and source control without waiting for imaging to become definitive.

Epidemiology / Risk Factors

• Cellulitis and skin abscesses are among the most common bacterial skin and soft tissue infections encountered in ambulatory and emergency care.
• Risk increases with chronic edema, lymphedema, venous insufficiency, obesity, diabetes, skin trauma, dermatologic barrier disease, and prior cellulitis.
• Community-associated MRSA is an important cause of purulent skin infection, but streptococci remain dominant pathogens in classic nonpurulent cellulitis.
• Recurrence is common when anatomic and skin-barrier risk factors persist.
• Older adults and immunocompromised patients may have muted fever or leukocytosis despite significant infection.

Investigations

When to Add MRSA Coverage

Pharmacology

Prognosis / Complications

• Most uncomplicated cellulitis and adequately drained abscesses improve with appropriate outpatient management.
• Clinical improvement in pain, fever, and spread is generally expected over the first 48 to 72 hours, although residual erythema and edema can last longer.
• Recurrence is more likely with persistent lymphedema, venous disease, obesity, interdigital fungal infection, and prior episodes.
• Bacteremia and metastatic infection are uncommon in mild disease but become more relevant with systemic toxicity or unusual hosts.
• Necrotizing soft tissue infection carries substantial morbidity and mortality, making early recognition and operative source control critical.

Patient Education / Counseling

• Explain whether the infection appears diffuse or contains a drainable collection, because the treatment strategy differs.
• Advise elevation of the affected limb when feasible and routine wound hygiene without squeezing or repeatedly manipulating an abscess.
• Return urgently for rapidly spreading redness, escalating or disproportionate pain, fever with weakness, new blisters or dark skin, confusion, fainting, or inability to take medication.
• Review the expected time course so persistent discoloration alone is not mistaken for failure when pain and systemic findings are improving.
• Discuss prevention by treating athlete's foot, protecting skin, controlling edema, and seeking care promptly for recurrent lesions.

Notes

Cellulitis and abscess should be approached as related but different syndromes. A patient with diffuse nonpurulent erythema usually needs targeted antimicrobial therapy and management of edema or skin-barrier disease. A patient with a true abscess needs mechanical source control. The dangerous diagnostic error is to treat a necrotizing infection, septic joint, orbital process, or other deep infection as routine cellulitis. Failure to improve should therefore prompt a fresh examination rather than simply broader antibiotics. When recurrent disease is the problem, prevention depends as much on correcting chronic edema, fungal toe-web disease, wounds, and skin trauma as on selecting the next antibiotic.

References

1. IDSA Practice Guideline for the Diagnosis and Management of Skin and Soft Tissue Infections — Link